Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuriko Sato

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Journal of Immunological Methods|November 26, 2002
Improved generation of HLA class I/peptide tetramersYuriko Sato, Hiroeki Sahara, Tomohide Tsukahara, et al.
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|August 5, 2003
Recognition by cellular and humoral autologous immunity in a human osteosarcoma cell lineYuki Nabeta, Satoshi Kawaguchi, Hiroeki Sahara, et al.
Journal of Translational Medicine|January 14, 2005
Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcomaSatoshi Kawaguchi, Takuro Wada, Kazunori Ida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2005
A potent immunogenic general cancer vaccine that targets survivin, an inhibitor of apoptosis proteinsSatomi Idenoue, Yoshihiko Hirohashi, Toshihiko Torigoe, et al.
Journal of Arrhythmia|September 1, 2018
Development of monomorphic ventricular tachycardia in a patient with fever-induced Brugada syndromeYuriko Sato, Yoshiyasu Aizawa, Taishi Fujisawa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 23, 2002
Detection and induction of CTLs specific for SYT-SSX-derived peptides in HLA-A24(+) patients with synovial sarcomaYuriko Sato, Yuki Nabeta, Tomohide Tsukahara, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2004
Crisscross CTL induction by SYT-SSX junction peptide and its HLA-A*2402 anchor substituteKazunori Ida, Satoshi Kawaguchi, Yuriko Sato, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Journal of Immunological Methods|November 26, 2002
Improved generation of HLA class I/peptide tetramersYuriko Sato, Hiroeki Sahara, Tomohide Tsukahara, et al.
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|August 5, 2003
Recognition by cellular and humoral autologous immunity in a human osteosarcoma cell lineYuki Nabeta, Satoshi Kawaguchi, Hiroeki Sahara, et al.
Journal of Translational Medicine|January 14, 2005
Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcomaSatoshi Kawaguchi, Takuro Wada, Kazunori Ida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2005
A potent immunogenic general cancer vaccine that targets survivin, an inhibitor of apoptosis proteinsSatomi Idenoue, Yoshihiko Hirohashi, Toshihiko Torigoe, et al.
Journal of Arrhythmia|September 1, 2018
Development of monomorphic ventricular tachycardia in a patient with fever-induced Brugada syndromeYuriko Sato, Yoshiyasu Aizawa, Taishi Fujisawa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 23, 2002
Detection and induction of CTLs specific for SYT-SSX-derived peptides in HLA-A24(+) patients with synovial sarcomaYuriko Sato, Yuki Nabeta, Tomohide Tsukahara, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2004
Crisscross CTL induction by SYT-SSX junction peptide and its HLA-A*2402 anchor substituteKazunori Ida, Satoshi Kawaguchi, Yuriko Sato, et al.
Pageof 5